Evidence map›Paper›PMID 41566477›Full record

ReviewMolecular cancer2026

LncRNA PVT1 in human cancers: genomic complexity, isoforms, functional elements, mechanism of action, subcellular localization and possible role as a therapeutic target.

Chen Li, Francisco Alejandro Lagunas-Rangel, Lutao Du, Chengxi Sun, Helgi B Schiöth

Abstract readReview
In one paragraph

Review in Molecular cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chen LiDepartment of Clinical Laboratory, The Second Qilu Hospital of Shandong University, 247 Beiyuan Street, Jinan, Shandong, 250033, China.ORCID http://orcid.org/0000-0002-7199-4298
Francisco Alejandro Lagunas-RangelDepartment of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
Lutao DuDepartment of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, China.
Chengxi SunDepartment of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden. sunchengxi_qljy@sdu.edu.cn.ORCID http://orcid.org/0000-0002-1050-5956
Helgi B SchiöthDepartment of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden. Helgi.schioth@uu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PVT1 (Plasmacytoma Variant Translocation 1), a long non-coding RNA (lncRNA), is a critical player in diverse biological processes, particularly cancer biology. This review comprehensively examines PVT1’s multifaceted roles and molecular mechanisms. We delve into its predominant oncogenic functions while highlighting notable exceptions, offering new perspectives on its biological diversity. A key focus is the subcellular localizations of PVT1 across various cancers – an aspect underexplored in previous reviews despite its significant impact on function and regulatory mechanisms. Detailed mechanistic insights include PVT1’s linear and circular isoforms acting as miRNA sponges, its encoding of miRNAs, the influence of 8q24 rearrangements, and its regulation of protein stability/activity, and transcription. Furthermore, we examine PVT1’s functional elements, illuminating unexplored structural and regulatory features. The clinical implications of PVT1 as a biomarker and therapeutic target in oncology are also discussed. By synthesizing existing knowledge and introducing previously less-explored facets, this review aims to provide a comprehensive and up-to-date resource on PVT1’s role in health and disease.

Indexed as

GenomicsNeoplasmsRNA, Long NoncodingAnimalsBiomarkers, TumorGene Expression Regulation, NeoplasticHumansMicroRNAsMolecular Targeted TherapyBiomarkers, TumorMicroRNAsPVT1 long-non-coding RNA, humanRNA, Long NoncodingAntagomirsCancer mechanismsCRISPR/Cas9 therapeuticsMiRNA spongingPVT1

Identifiers

PMID41566477
PMCPMC12952124

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.